Rice Z, Gooderham M, Lebwohl MG, Simpson EL, Boguniewicz M, Wollenberg A, Lazariciu I, Chan GL, Alderfer J, Watkins M. Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 3];7(2):s154. Available from: https://jofskin.org/33014/index.php/skin/article/view/1980